The objective of the study is to evaluate the safety and efficacy of Mucinex D tablets in
providing symptom relief when administered as an adjunct to antibiotic therapy in patients
with acute respiratory infection.
Phase:
Phase 4
Details
Lead Sponsor:
Adams Respiratory Therapeutics
Treatments:
Chlorpheniramine, phenylpropanolamine drug combination Ephedrine Guaifenesin Phenylpropanolamine Pseudoephedrine